CFO pay
Pharmaceuticals & Biotechnology
Public companies in this sector. The median CFO was paid $1.5M; the middle half $678K to $3.2M.
| Company | CFO | Total pay | Year |
|---|---|---|---|
| 4D Molecular Therapeutics, Inc. | Kristian Humer | $4M | 2025 |
| 60 DEGREES PHARMACEUTICALS, INC. | Tyrone Miller | $283K | 2025 |
| Aardvark Therapeutics, Inc. | Nelson Sun | $2.5M | 2025 |
| ABBOTT LABORATORIES | Philip P. Boudreau | $9.1M | 2025 |
| AbbVie Inc. | Scott T. Reents | $12.4M | 2025 |
| AbCellera Biologics Inc. | Andrew Booth | $3.4M | 2025 |
| ABEONA THERAPEUTICS INC. | Joseph Vazzano | $1.7M | 2025 |
| ACADIA PHARMACEUTICALS INC | Mark C. Schneyer | $3.1M | 2025 |
| Aclaris Therapeutics, Inc. | Kevin Balthaser | $1.5M | 2025 |
| Actinium Pharmaceuticals, Inc. | Steve O'Loughlin | $546K | 2025 |
| ACTUATE THERAPEUTICS, INC. | Paul Lytle | $1M | 2025 |
| Acumen Pharmaceuticals, Inc. | Matthew Zuga | $949K | 2025 |
| Acurx Pharmaceuticals, Inc. | Robert G. Shawah | $503K | 2025 |
| Adaptive Biotechnologies Corp | Kyle Piskel | $3.3M | 2025 |
| ADC Therapeutics SA | Jose "Pepe" Carmona | $1.2M | 2025 |
| ADIAL PHARMACEUTICALS, INC. | Vinay Shah | $459K | 2025 |
| Aditxt, Inc. | Thomas J. Farley | $395K | 2025 |
| ADMA BIOLOGICS, INC. | Paul Terence Kohler | $2.3M | 2025 |
| AGIOS PHARMACEUTICALS, INC. | Cecilia Jones | $2.5M | 2025 |
| AIM ImmunoTech Inc. | Robert Dickey IV | $108K | 2025 |
| Akebia Therapeutics, Inc. | Erik J. Ostrowski | $1.8M | 2025 |
| Aldeyra Therapeutics, Inc. | Michael Alfieri | $246K | 2025 |
| Alector, Inc. | Neil Berkley | $1.1M | 2025 |
| Aligos Therapeutics, Inc. | Lesley Ann Calhoun | $1.6M | 2025 |
| Alkermes plc. | Joshua Reed | $3.8M | 2025 |
| Allarity Therapeutics, Inc. | Jeffrey S. Ervin | $159K | 2025 |
| Allogene Therapeutics, Inc. | Geoffrey Parker | $1.9M | 2025 |
| ALNYLAM PHARMACEUTICALS, INC. | Jeffrey V. Poulton | $6.9M | 2025 |
| Alpha Cognition Inc. | Henry Du | $465K | 2025 |
| Alpha Teknova, Inc. | Matthew Lowell | $1.2M | 2025 |
| Alto Neuroscience, Inc. | Nicholas Smith | $1.5M | 2025 |
| ALX ONCOLOGY HOLDINGS INC | Harish Shantharam | $1.7M | 2025 |
| Alzamend Neuro, Inc. | David J. Katzoff | $150K | 2025 |
| AMARIN CORP PLC\UK | Peter L. Fishman | $1M | 2025 |
| AMGEN INC | Peter H. Griffith | $8.6M | 2025 |
| Amneal Pharmaceuticals, Inc. | Anastasios Konidaris | $3.3M | 2025 |
| Amphastar Pharmaceuticals, Inc. | William J. Peters | $3.2M | 2025 |
| Amylyx Pharmaceuticals, Inc. | James Frates | $1.4M | 2025 |
| AN2 Therapeutics, Inc. | Lucy Day | $774K | 2025 |
| ANAPTYSBIO, INC | Dennis Mulroy | $2M | 2025 |
| ANAVEX LIFE SCIENCES CORP. | Sandra Boenisch | $402K | 2024 |
| Anebulo Pharmaceuticals, Inc. | Daniel George | $147K | 2024 |
| ANI PHARMACEUTICALS INC | Stephen P. Carey | $3.3M | 2025 |
| Anixa Biosciences Inc | Michael J. Catelani | $1.3M | 2025 |
| Annexon, Inc. | Jennifer Lew. | $1.3M | 2025 |
| Aprea Therapeutics, Inc. | John P. Hamill | $491K | 2025 |
| Aquestive Therapeutics, Inc. | A. Ernest Toth | $1.3M | 2025 |
| Arbutus Biopharma Corp | Tuan Nguyen | $2.4M | 2025 |
| Arcturus Therapeutics Holdings Inc. | Joe Roberts | $274K | 2025 |
| Arcus Biosciences, Inc. | Robert C. Goeltz | $2.7M | 2025 |
| Arcutis Biotherapeutics, Inc. | Latha Vairavan | $1.9M | 2025 |
| ARDELYX, INC. | Susan Hohenleitner | $3.4M | 2025 |
| Armata Pharmaceuticals, Inc. | David House | $555K | 2025 |
| ArriVent BioPharma, Inc. | Winston Kung | $3.4M | 2025 |
| ARROWHEAD PHARMACEUTICALS, INC. | Daniel Apel | $1.8M | 2025 |
| ARTELO BIOSCIENCES, INC. | Mark E. Spring | $291K | 2025 |
| ARVINAS, INC. | Andrew Saik | $3.4M | 2025 |
| Aspira Women's Health Inc. | Brian Hungerford | $141K | 2025 |
| Atara Biotherapeutics, Inc. | Eric Hyllengren | $1M | 2025 |
| Atea Pharmaceuticals, Inc. | Andrea Corcoran | $1.7M | 2025 |
| ATOSSA THERAPEUTICS, INC. | Mark J. Daniel | $536K | 2025 |
| Aura Biosciences, Inc. | Anthony Gibney | $2.8M | 2025 |
| Aurinia Pharmaceuticals Inc. | Joseph Miller | $2.1M | 2025 |
| AVENUE THERAPEUTICS, INC. | David Jin | $260K | 2023 |
| Axsome Therapeutics, Inc. | Nick Pizzie | $3.7M | 2025 |
| AYTU BIOPHARMA, INC | Ryan J. Selhorn | $566K | 2026 |
| Azitra, Inc. | Norman Staskey | $497K | 2025 |
| Bausch Health Companies Inc. | Jean-Jacques Charhon | $4.9M | 2025 |
| Beam Therapeutics Inc. | Sravan K. Emany | $1.3M | 2025 |
| Benitec Biopharma Inc. | Megan Boston | $3.2M | 2026 |
| BeOne Medicines Ltd. | Aaron Rosenberg | $6.4M | 2025 |
| BetterLife Pharma Inc. | Moira Ong | $630K | 2017 |
| BIO-TECHNE Corp | James Hippel | $7M | 2025 |
| BioAtla, Inc. | Richard A. Waldron | $516K | 2025 |
| BioCardia, Inc. | David McClung | $355K | 2024 |
| BIOCRYST PHARMACEUTICALS INC | Babar Ghias | $6.7M | 2025 |
| Biofrontera Inc. | Fred Leffler | $554K | 2025 |
| BIOGEN INC. | Robin C. Kramer | $5.8M | 2025 |
| Biohaven Ltd. | Matthew Buten | $4.5M | 2025 |
| BIOMARIN PHARMACEUTICAL INC | Brian R. Mueller | $6.8M | 2025 |
| Biomea Fusion, Inc. | Rainer (Ramses) Erdtmann | $2.2M | 2025 |
| BIOMERICA INC | Gary Lu | $387K | 2026 |
| biote Corp. | Robert Peterson | $1.5M | 2025 |
| BIOVIE INC. | Joanne Wendy Kim | $498K | 2026 |
| BioXcel Therapeutics, Inc. | Richard Steinhart | $998K | 2024 |
| Bolt Biotherapeutics, Inc. | William P. Quinn | $4.6M | 2025 |
| BriaCell Therapeutics Corp. | Mr. Gadi Levin | $535K | 2025 |
| BridgeBio Oncology Therapeutics, Inc. | Uneek Mehra | $4.6M | 2025 |
| BridgeBio Pharma, Inc. | Thomas Trimarchi | $5.8M | 2025 |
| BRISTOL MYERS SQUIBB CO | David V. Elkins | $9.2M | 2025 |
| BullFrog AI Holdings, Inc. | Josh Blacher | $254K | 2025 |
| C4 Therapeutics, Inc. | Kendra R. Adams | $1.5M | 2025 |
| Cadrenal Therapeutics, Inc. | Matthew Szot | $1.3M | 2025 |
| Calidi Biotherapeutics, Inc. | Andrew Jackson | $594K | 2025 |
| Camp4 Therapeutics Corp | Kelly Gold | $1.8M | 2025 |
| Candel Therapeutics, Inc. | Charles Schoch | $1.5M | 2025 |
| Canopy Growth Corp | Thomas Stewart | $1.3M | 2026 |
| CAPRICOR THERAPEUTICS, INC. | Anthony Bergmann | $1.7M | 2025 |
| Cardio Diagnostics Holdings, Inc. | Elisa Luqman | $275K | 2025 |
| Caribou Biosciences, Inc. | Sriram Ryali | $1M | 2025 |
| Cartesian Therapeutics, Inc. | Blaine Davis | $1.9M | 2025 |
| Celldex Therapeutics, Inc. | Sam Martin | $1.8M | 2025 |
| Cellectar Biosciences, Inc. | Chad J. Kolean | $620K | 2025 |
| Celularity Inc | David Beers | $445K | 2024 |
| CervoMed Inc. | William Elder | $686K | 2025 |
| CG Oncology, Inc. | Robert Lapetina | $645K | 2025 |
| CHAMPIONS ONCOLOGY, INC. | David Miller | $388K | 2026 |
| Charlie's Holdings, Inc. | Matthew P. Montesano | $124K | 2025 |
| Chemomab Therapeutics Ltd. | Donald Marvin | $196K | 2021 |
| Cingulate Inc. | Jennifer L. Callahan | $969K | 2025 |
| Clene Inc. | Morgan R. Brown | $488K | 2025 |
| Climb Bio, Inc. | Susan Altschuller | $1.2M | 2025 |
| Cocrystal Pharma, Inc. | James Martin | $265K | 2025 |
| Cogent Biosciences, Inc. | John Green | $8.5M | 2025 |
| COGNITION THERAPEUTICS INC | John Doyle | $867K | 2025 |
| Coherus Oncology, Inc. | Bryan McMichael | $1.1M | 2025 |
| COLLEGIUM PHARMACEUTICAL, INC | Colleen Tupper | $3.5M | 2025 |
| COMPASS Pathways plc | Teri Loxam | $1.1M | 2025 |
| Compass Therapeutics, Inc. | Barry Shin | $1.4M | 2025 |
| Context Therapeutics Inc. | Jennifer Minai-Azary | $866K | 2025 |
| Contineum Therapeutics, Inc. | Peter T. Slover | $1.6M | 2025 |
| Corbus Pharmaceuticals Holdings, Inc. | Sean Moran | $1.8M | 2025 |
| CORCEPT THERAPEUTICS INC | Atabak Mokari | $6.1M | 2025 |
| Corvus Pharmaceuticals, Inc. | Leiv Lea | $3.2M | 2025 |
| Coya Therapeutics, Inc. | David Snyder | $1.4M | 2025 |
| CRISPR Therapeutics AG | Raju Prasad | $3.6M | 2025 |
| Cronos Group Inc. | Anna Shlimak | $1.2M | 2025 |
| Cryoport, Inc. | Robert S. Stefanovich | $1.1M | 2025 |
| CTT PHARMACEUTICAL HOLDINGS, INC. | Greg Bowes | $23K | 2011 |
| Cullinan Therapeutics, Inc. | Mary Kay Fenton | $2.1M | 2025 |
| CV Sciences, Inc. | Joerg Grasser | $308K | 2025 |
| CYANOTECH CORP | Jennifer C. Rogerson | $114K | 2025 |
| CYPHERPUNK TECHNOLOGIES INC. | Douglas E. Onsi | $4.7M | 2025 |
| CytoDyn Inc. | Robert E. Hoffman | $1.9M | 2026 |
| CYTOKINETICS INC | Sung H. Lee | $3.8M | 2025 |
| CytomX Therapeutics, Inc. | Chris Ogden | $1.5M | 2025 |
| Damora Therapeutics, Inc. | Lori Firmani | $563K | 2025 |
| DBV Technologies S.A. | Virginie Boucinha | $1.1M | 2025 |
| Definium Therapeutics, Inc. | Brandi L. Roberts | $5.1M | 2025 |
| Denali Therapeutics Inc. | Alexander O. Schuth | $4.3M | 2025 |
| Dermata Therapeutics, Inc. | Kyri K. Van Hoose | $509K | 2025 |
| DiaMedica Therapeutics Inc. | Scott Kellen | $1.2M | 2025 |
| Dianthus Therapeutics, Inc. /DE/ | Ryan Savitz | $5.1M | 2025 |
| Disc Medicine, Inc. | Jean Franchi | $4.2M | 2025 |
| Dogwood Therapeutics, Inc. | Angela Walsh | $1.3M | 2025 |
| DYADIC INTERNATIONAL INC | Ping Rawson | $413K | 2025 |
| Dyne Therapeutics, Inc. | Erick Lucera | $2.7M | 2025 |
| Edesa Biotech, Inc. | Peter Weiler | $265K | 2025 |
| Edgewise Therapeutics, Inc. | Michael P. Nofi | $4.3M | 2025 |
| Editas Medicine, Inc. | Amy Parison | $822K | 2025 |
| Elanco Animal Health Inc | Robert VanHimbergen | $4.7M | 2025 |
| Eledon Pharmaceuticals, Inc. | Paul Little | $1.6M | 2025 |
| ELI LILLY & Co | Lucas Montarce | $8.5M | 2025 |
| Elicio Therapeutics, Inc. | Preetam Shah | $1.4M | 2025 |
| Eloxx Pharmaceuticals, Inc. | Daniel E. Geffken | $64K | 2022 |
| ELUTIA INC. | Matthew Ferguson | $747K | 2025 |
| Emergent BioSolutions Inc. | Richard Lindahl | $2.7M | 2025 |
| Emmaus Life Sciences, Inc. | Yasushi Nagasaki | $350K | 2021 |
| enGene Therapeutics Inc. | Ryan Daws | $2.2M | 2025 |
| Enliven Therapeutics, Inc. | Ben Hohl | $3.4M | 2025 |
| Ensysce Biosciences, Inc. | Dave Humphrey | $371K | 2024 |
| Enveric Biosciences, Inc. | Kevin Coveney | $678K | 2025 |
| Erasca, Inc. | David M. Chacko | $1.8M | 2025 |
| Eton Pharmaceuticals, Inc. | James R. Gruber | $1.4M | 2025 |
| Evofem Biosciences, Inc. | Ivy Zhang | $695K | 2024 |
| Evolus, Inc. | Tatjana Mitchell | $3.2M | 2025 |
| Evommune, Inc. | Kyle Carver | $4.4M | 2025 |
| EXELIXIS, INC. | Christopher J. Senner | $10.6M | 2025 |
| EXICURE, INC. | Seung Ik Baik | $6K | 2024 |
| FATE THERAPEUTICS INC | Kamal Adawi | $715K | 2025 |
| FENNEC PHARMACEUTICALS INC. | Robert Andrade | $1.9M | 2025 |
| FILANA THERAPEUTICS, INC. | Eric J. Schoen | $830K | 2025 |
| FITLIFE BRANDS, INC. | Jakob York | $318K | 2025 |
| Fortress Biotech, Inc. | David Jin | $664K | 2025 |
| Fulcrum Therapeutics, Inc. | Alan Musso | $1.8M | 2025 |
| Gain Therapeutics, Inc. | Gianluca Fuggetta | $345K | 2025 |
| GALECTIN THERAPEUTICS INC | Jack W. Callicutt | $807K | 2025 |
| GENELUX Corp | Matthew Pulisic | $1.5M | 2025 |
| Genprex, Inc. | Ryan M. Confer | $729K | 2025 |
| GERON CORP | Michelle J. Robertson | $2.3M | 2025 |
| GILEAD SCIENCES, INC. | Andrew D. Dickinson | $8.8M | 2025 |
| Ginkgo Bioworks Holdings, Inc. | Steven Coen | $1.3M | 2025 |
| GRI Bio, Inc. | Leanne Kelly | $585K | 2025 |
| GYRE THERAPEUTICS, INC. | Ruoyu Chen | $286K | 2025 |
| HALOZYME THERAPEUTICS, INC. | Nicole LaBrosse | $4.6M | 2025 |
| Harmony Biosciences Holdings, Inc. | Sandip Kapadia | $3.2M | 2025 |
| HARROW, INC. | Andrew R. Boll | $10.9M | 2025 |
| Hepion Pharmaceuticals, Inc. | John Brancaccio | $233K | 2025 |
| HERON THERAPEUTICS, INC. /DE/ | Ira Duarte | $1.6M | 2025 |
| Humacyte, Inc. | Dale A. Sander | $2.1M | 2025 |
| iBio, Inc. | Felipe Duran | $1.1M | 2026 |
| IDEAYA Biosciences, Inc. | Joshua Bleharski | $4.1M | 2025 |
| IDEXX LABORATORIES INC /DE | Andrew Emerson | $3M | 2025 |
| ImageneBio, Inc. | Jotin Marango | $1.6M | 2025 |
| Immix Biopharma, Inc. | Gabriel Morris | $1.4M | 2025 |
| IMMUCELL CORP /DE/ | Timothy C. Fiori | $369K | 2025 |
| IMMUNIC, INC. | Glenn Whaley | $1.1M | 2025 |
| ImmunityBio, Inc. | David Sachs | $4.2M | 2025 |
| Immunocore Holdings plc | Travis Coy | $5.2M | 2025 |
| Immunome Inc. | Max Rosett | $2.8M | 2025 |
| Immunovant, Inc. | Tiago Girão | $7.6M | 2026 |
| IMPACT BIOMEDICAL INC. | Todd D. Macko | $555 | 2024 |
| IN8BIO, INC. | Patrick McCall | $677K | 2025 |
| Incannex Healthcare Inc. | Joseph Swan | $466K | 2026 |
| Indivior Pharmaceuticals, Inc. | Ryan Preblick | $3.6M | 2025 |
| Inhibikase Therapeutics, Inc. | David McIntyre | $5.5M | 2025 |
| Inhibitor Therapeutics, Inc. | James A. McNulty | $363K | 2025 |
| Inhibrx Biosciences, Inc. | Kelly D. Deck | $924K | 2025 |
| InMed Pharmaceuticals Inc. | Netta Jagpal | $304K | 2025 |
| Inmune Bio, Inc. | Cory Ellspermann | $619K | 2025 |
| Innoviva, Inc. | Stephen Basso | $2.2M | 2025 |
| INOVIO PHARMACEUTICALS, INC. | Peter D. Kies | $834K | 2025 |
| Insight Molecular Diagnostics Inc. | Andrea James | $1.7M | 2025 |
| INSMED Inc | Sara Bonstein | $4.6M | 2025 |
| Instil Bio, Inc. | Sandeep Laumas | $1.2M | 2025 |
| INTEGRATED BIOPHARMA INC | Dina Masi | $361K | 2026 |
| Intellia Therapeutics, Inc. | Edward J. Dulac III | $2.2M | 2025 |
| INTENSITY THERAPEUTICS, INC. | Joseph Talamo | $724K | 2025 |
| Invivyd, Inc. | William Duke | $2.1M | 2025 |
| IONIS PHARMACEUTICALS INC | Elizabeth L. Hougen | $4.4M | 2025 |
| IOVANCE BIOTHERAPEUTICS, INC. | Matthew W. Rosinack | $782K | 2025 |
| IRONWOOD PHARMACEUTICALS INC | Gregory Martini | $1.2M | 2025 |
| Jade Biosciences, Inc. | Bradford Dahms | $4.1M | 2025 |
| Jazz Pharmaceuticals plc | Philip L. Johnson | $7.5M | 2025 |
| JOHNSON & JOHNSON | J. Wolk | $14.4M | 2025 |
| Journey Medical Corp | Joseph Benesch | $824K | 2025 |
| JUPITER NEUROSCIENCES, INC. | Saleem Elmasri | $414K | 2025 |
| Jushi Holdings Inc. | Michelle Mosier | $770K | 2025 |
| KALA BIO, Inc. | Mary Reumuth | $1.3M | 2025 |
| Kalaris Therapeutics, Inc. | Vikas Sinha | $1.1M | 2025 |
| Keros Therapeutics, Inc. | Keith Regnante | $1.1M | 2025 |
| Kiniksa Pharmaceuticals International, plc | Mark Ragosa | $3.3M | 2025 |
| KIORA PHARMACEUTICALS INC | Melissa Tosca | $517K | 2025 |
| Korro Bio, Inc. | Ram Aiyar | $3.1M | 2025 |
| Kymera Therapeutics, Inc. | Bruce Jacobs | $2.9M | 2025 |
| KYNTRA BIO, INC. | David DeLucia | $1.1M | 2025 |
| Kyverna Therapeutics, Inc. | Marc Grasso | $1.7M | 2025 |
| Lakewood-Amedex Biotherapeutics Inc. | Peter Ceccacci | $533K | 2025 |
| Lantern Pharma Inc. | David R. Margrave | $586K | 2025 |
| Lantheus Holdings, Inc. | Robert J. Marshall | $5.2M | 2025 |
| Lexaria Bioscience Corp. | Michael Shankman | $248K | 2025 |
| Lexeo Therapeutics, Inc. | Louis Tamayo | $1.7M | 2025 |
| LianBio | Yi Larson | $7.8M | 2021 |
| Lifevantage Corp | Carl Aure | $757K | 2026 |
| LIGAND PHARMACEUTICALS INC | Tavo Espinoza | $4.4M | 2025 |
| Lineage Cell Therapeutics, Inc. | Jill A. Howe | $1M | 2025 |
| Liquidia Corp | Michael Kaseta | $4.2M | 2025 |
| Longeveron Inc. | Lisa A. Locklear | $862K | 2025 |
| MACROGENICS INC | James Karrels | $1.1M | 2025 |
| MADRIGAL PHARMACEUTICALS, INC. | Mardi Dier | $6.1M | 2025 |
| MANNATECH INC | James Clavijo | $290K | 2025 |
| MANNKIND CORP | Christopher B. Prentiss | $2.9M | 2025 |
| MapLight Therapeutics, Inc. | Vishwas Setia | $6.2M | 2025 |
| MARAVAI LIFESCIENCES HOLDINGS, INC. | Raj Asarpota | $3.5M | 2025 |
| Matinas BioPharma Holdings, Inc. | Keith Kucinski | $584K | 2024 |
| Maze Therapeutics, Inc. | Misbah Tahir | $4M | 2025 |
| MBX Biosciences, Inc. | Richard Bartram | $1.5M | 2025 |
| MeiraGTx Holdings plc | Richard Giroux | $8.1M | 2025 |
| Merck & Co., Inc. | Caroline Litchfield | $7.5M | 2025 |
| Mereo BioPharma Group plc | Christine Fox | $1.1M | 2025 |
| Metagenomi Therapeutics, Inc. | Pamela Wapnick | $935K | 2025 |
| MetaVia Inc. | Marshall H. Woodworth | $563K | 2025 |
| Milestone Pharmaceuticals Inc. | Amit Hasija | $992K | 2025 |
| Mineralys Therapeutics, Inc. | Adam Levy | $2.2M | 2025 |
| Minerva Neurosciences, Inc. | Frederick Ahlholm | $2.5M | 2025 |
| MIRA PHARMACEUTICALS, INC. | Alan Weichselbaum | $124K | 2025 |
| Mirum Pharmaceuticals, Inc. | Eric Bjerkholt | $3.2M | 2025 |
| Moderna, Inc. | James Mock | $5.9M | 2025 |
| Moleculin Biotech, Inc. | Jonathan P. Foster | $907K | 2025 |
| Monopar Therapeutics | Quan Vu | $2.1M | 2025 |
| MoonLake Immunotherapeutics | Matthias Bodenstedt | $4.7M | 2025 |
| Mosaic ImmunoEngineering Inc. | Clifford L. Flowers | $339K | 2017 |
| MUSTANG BIO, INC. | Manuel Litchman | $498K | 2024 |
| MYRIAD GENETICS INC | Benjamin R. Wheeler | $1.5M | 2025 |
| NANOVIRICIDES, INC. | Meeta Vyas | $135K | 2026 |
| NATURAL ALTERNATIVES INTERNATIONAL INC | Michael E. Fortin | $516K | 2026 |
| NATURES SUNSHINE PRODUCTS INC | Shane Jones | $1.7M | 2025 |
| NEKTAR THERAPEUTICS | Sandra Gardiner | $686K | 2025 |
| NEOGEN CORP | R. Bryan Riggsbee (⁸) | $3.3M | 2026 |
| NEONC TECHNOLOGIES HOLDINGS, INC. | Keithly Garnett - | $179K | 2025 |
| Neuphoria Therapeutics Inc. | Tim Cunningham | $326K | 2026 |
| NEUROCRINE BIOSCIENCES INC | Matthew C. Abernethy | $6.3M | 2025 |
| Neurogene Inc. | Christine Mikail | $2.8M | 2025 |
| NewAmsterdam Pharma Co N.V. | Ian Somaiya | $4.7M | 2025 |
| Niagen Bioscience, Inc. | Ozan Pamir | $716K | 2025 |
| NORTHWEST BIOTHERAPEUTICS INC | Linda F. Powers | $1.2M | 2024 |
| NOVAVAX INC | James P. Kelly | $3M | 2025 |
| NRX Pharmaceuticals, Inc. | Michael Abrams | $20K | 2024 |
| Nurix Therapeutics, Inc. | Hans van Houte | $2.3M | 2025 |
| Nuvation Bio Inc. | Philippe Sauvage | $1.5M | 2025 |
| OCULAR THERAPEUTIX, INC | Donald Notman | $3.7M | 2025 |
| Olema Pharmaceuticals, Inc. | Shane Kovacs | $1.9M | 2025 |
| ONCOLYTICS BIOTECH INC | Kirk Look | $1.1M | 2025 |
| Onconetix, Inc. | Karina Fedasz | $352K | 2025 |
| Oncotelic Therapeutics, Inc. | Amit Shah | $193K | 2019 |
| OnKure Therapeutics, Inc. | Jason Leverone | $896K | 2025 |
| OPKO HEALTH, INC. | Adam Logal | $1.5M | 2025 |
| ORAGENICS INC | Janet Huffman | $609K | 2025 |
| Organogenesis Holdings Inc. | David Francisco | $2M | 2025 |
| Organon & Co. | Matthew Walsh | $5.7M | 2025 |
| Oric Pharmaceuticals, Inc. | Dominic Piscitelli | $2.2M | 2025 |
| OS Therapies Inc | Christopher P. Acevedo | $280K | 2025 |
| Pacira BioSciences, Inc. | Shawn Cross | $2.7M | 2024 |
| PALATIN TECHNOLOGIES INC | Stephen T. Wills | $688K | 2025 |
| PALISADE BIO, INC. | J.D. Finley | $18.8M | 2025 |
| PALVELLA THERAPEUTICS, INC. | Matthew E. Korenberg | $2M | 2025 |
| Pasithea Therapeutics Corp. | Daniel Schneiderman | $895K | 2025 |
| Passage BIO, Inc. | Kathleen Borthwick | $852K | 2025 |
| Pelthos Therapeutics Inc. | Francis Knuettel II | $2.3M | 2025 |
| PepGen Inc. | Noel P. Donnelly | $1.8M | 2025 |
| PERRIGO Co plc | Eduardo Bezerra | $3.7M | 2025 |
| PFIZER INC | D. Denton | $9.7M | 2025 |
| PharmaCyte Biotech, Inc. | Carlos A. Trujillo | $482K | 2025 |
| Phathom Pharmaceuticals, Inc. | Sanjeev Narula | $3.6M | 2025 |
| PHIBRO ANIMAL HEALTH CORP | Glenn David | $1.3M | 2026 |
| Phio Pharmaceuticals Corp. | Lisa C. Carson | $373K | 2025 |
| PLIANT THERAPEUTICS, INC. | Keith Cummings | $2.4M | 2025 |
| Pluri Inc. | Liat Zalts | $590K | 2025 |
| PMGC Holdings Inc. | Graydon Bensler | $698K | 2025 |
| Polaryx Therapeutics, Inc. | G. Michael Landis | $311K | 2025 |
| Praxis Precision Medicines, Inc. | Timothy Kelly | $3.2M | 2025 |
| PRECIGEN, INC. | Harry Thomasian Jr. | $1.5M | 2025 |
| PRECISION BIOSCIENCES INC | Alex Kelly | $1.1M | 2025 |
| Prelude Therapeutics Inc | Bryant D. Lim | $847K | 2025 |
| Processa Pharmaceuticals, Inc. | Russell Skibsted | $567K | 2025 |
| PROCYON CORP | James B. Anderson | $212K | 2023 |
| PROKIDNEY CORP. | James Coulston | $1.4M | 2025 |
| Protagonist Therapeutics, Inc | Asif Ali | $3.3M | 2025 |
| Protalix BioTherapeutics, Inc. | Eyal Rubin | $832K | 2025 |
| PROTHENA CORP PUBLIC LTD CO | Tran B. Nguyen | $2.7M | 2025 |
| PROVECTUS BIOPHARMACEUTICALS, INC. | Heather Raines | $200K | 2025 |
| PTC THERAPEUTICS, INC. | Pierre Gravier | $3.6M | 2025 |
| Pulmatrix, Inc. | Peter Ludlum | $510K | 2023 |
| PUMA BIOTECHNOLOGY, INC. | Maximo F. Nougues | $1.2M | 2025 |
| Q32 Bio Inc. | Lee Kalowski | $987K | 2025 |
| Quantum Cyber N.V. | William Caragol | $572K | 2025 |
| QuidelOrtho Corp | Joseph M. Busky | $5.4M | 2025 |
| Rafael Holdings, Inc. | David Polinsky | $527K | 2025 |
| Rani Therapeutics Holdings, Inc. | Svai Sanford | $946K | 2025 |
| Rapport Therapeutics, Inc. | Troy Ignelzi | $2.5M | 2025 |
| RECURSION PHARMACEUTICALS, INC. | Ben Taylor | $1.3M | 2025 |
| REGENERON PHARMACEUTICALS, INC. | Christopher Fenimore | $7M | 2025 |
| Rein Therapeutics, Inc. | Timothy M. Cunningham | $434K | 2025 |
| Relay Therapeutics, Inc. | Thomas Catinazzo | $1.6M | 2025 |
| RELMADA THERAPEUTICS, INC. | Maged Shenouda | $6.1M | 2025 |
| REPLIGEN CORP | Jason K. Garland | $3M | 2025 |
| Replimune Group, Inc. | Emily Hill | $2.1M | 2026 |
| REVELATION BIOSCIENCES, INC. | Chester S. Zygmont | $1.2M | 2025 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Narayan Prabhu | $405K | 2024 |
| Revolution Medicines, Inc. | Jack Anders | $3.6M | 2025 |
| Rezolute, Inc. | Daron Evans | $2.3M | 2026 |
| RHYTHM PHARMACEUTICALS, INC. | Hunter C. Smith | $6.2M | 2025 |
| ROCKET PHARMACEUTICALS, INC. | Martin Wilson | $3.4M | 2025 |
| ROCKWELL MEDICAL, INC. | Jesse Neri | $829K | 2025 |
| Roivant Sciences Ltd. | Richard Pulik | $4.2M | 2025 |
| Royalty Pharma plc | Terrance Coyne | $1.3M | 2025 |
| SAB Biotherapeutics, Inc. | Lucy To | $2.8M | 2025 |
| SANGAMO THERAPEUTICS, INC | Prathyusha Duraibabu | $1.2M | 2024 |
| Sarepta Therapeutics, Inc. | Ryan H. Wong | $3.2M | 2025 |
| Scholar Rock Holding Corp | Vikas Sinha | $12.9M | 2025 |
| Schrodinger, Inc. | Geoffrey Porges | $2M | 2025 |
| Scienture Holdings, Inc. | Dr. Narasimhan Mani | $1.3M | 2025 |
| Scilex Holding Co | Stephen Ma | $1.5M | 2025 |
| SCYNEXIS INC | Ivor Macleod | $859K | 2025 |
| SELLAS Life Sciences Group, Inc. | John T. Burns | $960K | 2025 |
| Semnur Pharmaceuticals, Inc. | Stephen Ma | $151K | 2025 |
| Senti Biosciences Holdings, Inc. | Yvonne Li | $548K | 2024 |
| Septerna, Inc. | Gil M. Labrucherie | $3.2M | 2025 |
| Seres Therapeutics, Inc. | Marella Thorell | $1.1M | 2025 |
| Shattuck Labs, Inc. | Andrew R. Neill | $883K | 2025 |
| SIGA TECHNOLOGIES INC | Daniel J. Luckshire | $1.6M | 2025 |
| Silence Therapeutics plc | Rhonda Hellums | $1.2M | 2025 |
| Silo Pharma, Inc. | Daniel Ryweck | $89K | 2024 |
| Sionna Therapeutics, Inc. | Elena Ridloff | $2.9M | 2025 |
| SKINVISIBLE, INC. | Terry Howlett | $180K | 2017 |
| Skye Bioscience, Inc. | Kaitlyn Arsenault | $889K | 2025 |
| Spero Therapeutics, Inc. | Esther Rajavelu | $2.1M | 2025 |
| SPRUCE BIOSCIENCES, INC. | Samir Gharib | $1.5M | 2025 |
| Spyre Therapeutics, Inc. | Scott Burrows | $2.2M | 2025 |
| STANDARD BIOTOOLS INC. | Alex Kim | $4M | 2025 |
| Stoke Therapeutics, Inc. | Thomas Leggett | $1.8M | 2025 |
| Structure Therapeutics Inc. | Jun Yoon | $4.5M | 2025 |
| SUPERNUS PHARMACEUTICALS, INC. | Timothy C. Dec | $1.9M | 2025 |
| SUTRO BIOPHARMA, INC. | Gregory Chow | $855K | 2025 |
| Syndax Pharmaceuticals Inc | Keith A. Goldan | $2.5M | 2025 |
| Synergy CHC Corp. | Jaime Fickett | $394K | 2025 |
| SYNLOGIC, INC. | Mary Beth Dooley | $486K | 2024 |
| TALPHERA, INC. | Raffi Asadorian | $727K | 2025 |
| Tango Therapeutics, Inc. | Daniella Beckman | $1.2M | 2025 |
| Tarsus Pharmaceuticals, Inc. | Jeffrey Farrow | $2.7M | 2025 |
| Taysha Gene Therapies, Inc. | Kamran Alam | $2.1M | 2025 |
| Tectonic Therapeutic, Inc. | Daniel Lochner | $3.1M | 2025 |
| Telomir Pharmaceuticals, Inc. | Alan Weichselbaum | $140K | 2025 |
| Tempest Therapeutics, Inc. | Nicholas Maestas | $1.1M | 2025 |
| TENAX THERAPEUTICS, INC. | Thomas A. McGauley | $475K | 2025 |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Eli Kalif | $7M | 2025 |
| Tevogen Inc. | Kirti Desai | $1.2M | 2025 |
| TG THERAPEUTICS, INC. | Sean A. Power | $3.8M | 2025 |
| TherapeuticsMD, Inc. | Joseph Ziegler | $120K | 2024 |
| Tilray Brands, Inc. | Carl Merton | $3.2M | 2026 |
| Tonix Pharmaceuticals Holding Corp. | Bradley Saenger | $1.1M | 2025 |
| Transcode Therapeutics, Inc. | Thomas A. Fitzgerald | $1.1M | 2025 |
| Travere Therapeutics, Inc. | Christopher Cline | $2.3M | 2025 |
| TuHURA Biosciences, Inc./NV | Dan Dearborn | $1.8M | 2025 |
| Turn Therapeutics Inc. | Zuraiz Chaudhary | $1.4M | 2025 |
| Tvardi Therapeutics, Inc. | Dan Conn | $1.1M | 2025 |
| Twist Bioscience Corp | Adam Laponis | $4.2M | 2025 |
| Ultragenyx Pharmaceutical Inc. | Howard Horn | $3.8M | 2025 |
| uniQure N.V. | Christian Klemt | $2.4M | 2025 |
| UNITED THERAPEUTICS Corp | James Edgemond | $8.3M | 2025 |
| Upstream Bio, Inc. | Michael Paul Gray | $2M | 2025 |
| USANA HEALTH SCIENCES INC | G. Douglas Hekking | $1.7M | 2025 |
| Vanda Pharmaceuticals Inc. | Kevin Moran | $1.4M | 2025 |
| Vaxcyte, Inc. | Andrew Guggenhime | $6.1M | 2025 |
| Vera Therapeutics, Inc. | Sean Grant | $2.7M | 2025 |
| Verastem, Inc. | Daniel Calkins | $977K | 2025 |
| Vericel Corp | Joe Mara | $3.2M | 2025 |
| Verrica Pharmaceuticals Inc. | John J. Kirby | $615K | 2025 |
| VERTEX PHARMACEUTICALS INC / MA | Charles F. Wagner | $8.2M | 2025 |
| Viatris Inc | Doretta Mistras | $5.6M | 2025 |
| Viking Therapeutics, Inc. | Greg Zante | $5.1M | 2025 |
| Vir Biotechnology, Inc. | Jason O'Byrne | $2M | 2025 |
| Vireo Growth Inc. | Tyson Macdonald | $10.3M | 2025 |
| Viridian Therapeutics, Inc.\DE | Seth Harmon | $2.6M | 2025 |
| VivoSim Labs, INC. | Norman Staskey | $119K | 2026 |
| Vor Biopharma Inc. | Sandesh Mahatme | $39.4M | 2025 |
| vTv Therapeutics Inc. | Michael Tung | $2.4M | 2025 |
| Vyome Holdings, Inc | Robert Dickey IV | $101K | 2025 |
| Wave Life Sciences, Inc. | Kyle Moran | $3.8M | 2025 |
| Werewolf Therapeutics, Inc. | Timothy W. Trost | $1.2M | 2024 |
| Whitehawk Therapeutics, Inc. | Scott Giacobello | $2.1M | 2025 |
| X4 Pharmaceuticals, Inc | David Kirske | $4.6M | 2025 |
| Xencor Inc | Bart Jan Cornelissen | $1.6M | 2025 |
| Xenetic Biosciences, Inc. | James Parslow | $481K | 2024 |
| Xenon Pharmaceuticals Inc. | Thomas Kelly | $7.2M | 2025 |
| Xeris Biopharma Holdings, Inc. | Steven M. Pieper | $1.9M | 2025 |
| Xilio Therapeutics, Inc. | Christopher Frankenfield | $3.2M | 2025 |
| Zai Lab Ltd | Yajing Chen | $3.2M | 2025 |
| ZEVRA THERAPEUTICS, INC. | R. LaDuane Clifton | $3.8M | 2025 |
| Zivo Bioscience, Inc. | Keith Marchiando | $324K | 2024 |
| Zoetis Inc. | Wetteny Joseph | $5.6M | 2025 |
| Zura Bio Ltd | Eric Hyllengren | $1M | 2025 |
| ZyVersa Therapeutics, Inc. | Peter Wolfe | $395K | 2024 |
Source: each company's latest definitive proxy statement (SEC Form DEF 14A), Summary Compensation Table. Figures are as reported. Snapshot as of 2026-11-02. Private-company pay is not covered, and smaller reporting companies may omit the CFO under Item 402(m).